Save Money / Consumer News
Counterfeit Botox may have shipped to California doctors
LOS ANGELES (KABC) -- The U.S. Food and Drug Administration is warning doctors that they may have received unapproved versions of Botox.
Federal regulators say a Canadian supplier shipped out versions of the popular wrinkle treatment that's unapproved by the FDA and possibly counterfeit. The agency said it cannot assure the products' effectiveness or safety.
The FDA says the supplier, Canada Drugs, has shipped out fake cancer drugs in the past. The company also operates under the following names: Quality Specialty Products (QSP), A+ Health Supplies, QP Medical, Bridgewater Medical or Clinical Care.
According to federal officials, many of the products sold and distributed by the above suppliers have not been approved by the FDA.
The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.
The FDA sent warning letters to more than 350 medical offices in the U.S., including some local doctors in Southern California.
The Associated Press contributed to this report.
fda, health, save money / consumer news
- Target probe focuses on processing centers 1 min ago
- Fallbrook tour bus crash: Victim identified
- Obama: 2014 can be breakthrough year for US
- Help Garth stuff buses full of toys in Anaheim
- Lancaster woman found dead; sons questioned
- Man found dead after house fire in Orange
- Calif. jobless rate continues positive trend
- Harry Reid in the hospital for observation
- Judge strikes down Utah's same-sex marriage ban
- Helicopter gunships used in MX resort battle
- abcnews: Service dog sniffs out girl's disease
- Bejo's 'Past' character sometimes unlikeable 7 min ago
- 9-yr-old FL girl is youngest to bowl 300 game
- OTRC: Phil Robertson's fam talks 'Duck Dynasty' future 25 min ago